Public Profile

BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc. (BDSI), headquartered in the United States, is a pioneering biopharmaceutical company focused on developing and commercialising innovative therapeutics for patients with chronic pain and substance use disorders. Founded in 1997, BDSI has achieved significant milestones, including the successful launch of its flagship product, BELBUCA®, a buprenorphine film that offers a unique delivery system for pain management. Operating primarily in the biopharmaceutical industry, BDSI is dedicated to advancing its proprietary drug delivery technologies, which enhance the efficacy and safety of its products. With a strong market position, BDSI has garnered recognition for its commitment to improving patient outcomes and addressing unmet medical needs. The company continues to expand its portfolio, solidifying its role as a leader in the field of pain management and addiction treatment.

DitchCarbon Score

How does BioDelivery Sciences International, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

BioDelivery Sciences International, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

BioDelivery Sciences International, Inc.'s reported carbon emissions

BioDelivery Sciences International, Inc., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data and commitments, it is unclear how BioDelivery Sciences is addressing climate change or its carbon footprint. The company may still be evaluating its strategies or aligning with industry standards for sustainability, but further information would be necessary to provide a comprehensive overview of its climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. BioDelivery Sciences International, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for BioDelivery Sciences International, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

BioDelivery Sciences International, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Mallinckrodt plc

IE
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Vectura Group Services Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

ANI Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Ironwood Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Acorda Therapeutics, Inc.

US
Health and social work services (85)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers